<p style="text-align:left;" class="MsoNormal" dir="LTR"><span style="line-height:150%">The funding includes an additional $20.6 million on top of $9.4 million of existing funds that have been reallocated for the fight against COVID-19. It will be pumped into initiatives that tackle the health and economic implications of the coronavirus pandemic, such as manufacturing rapid diagnostic tests for developing countries, and reducing the long-term impact of the potential economic fallout of COVID-19.</span></p>
